Literature DB >> 16296811

Applications of biomimetic systems in drug delivery.

Siddarth Venkatesh1, Mark E Byrne, Nicholas A Peppas, J Zach Hilt.   

Abstract

This review article highlights recent activities in the field of biomimetic systems and their application in controlled drug delivery. A definition and overview of biomimetic processes is given, with a focus on synthesis and assembly for the creation of novel biomaterials. In particular, systems are classified on the basis of three subsets, which include biological, biohybrid and synthetic structures. Examples focus on the current and proposed clinical significance for systems that mimic processes where the underlying molecular principles are well understood. Biomimetic materials and systems are presented as exceptional candidates for various controlled drug delivery applications and have enormous potential in medicine for the treatment of disease.

Mesh:

Substances:

Year:  2005        PMID: 16296811     DOI: 10.1517/17425247.2.6.1085

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  4 in total

Review 1.  Nanovehicular intracellular delivery systems.

Authors:  Ales Prokop; Jeffrey M Davidson
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

2.  Guided Cell Migration on Microtextured Substrates with Variable Local Density and Anisotropy.

Authors:  Deok-Ho Kim; Chang-Ho Seo; Karam Han; Keon Woo Kwon; Andre Levchenko; Kahp-Yang Suh
Journal:  Adv Funct Mater       Date:  2009-02-06       Impact factor: 18.808

Review 3.  Biologics and their delivery systems: Trends in myocardial infarction.

Authors:  Matthew A Borrelli; Heth R Turnquist; Steven R Little
Journal:  Adv Drug Deliv Rev       Date:  2021-03-26       Impact factor: 17.873

4.  Bio-mimetic drug delivery systems designed to help the senior population reconstruct melatonin plasma profiles similar to those of the healthy younger population.

Authors:  Ying Li; Liuyi Wang; Li Wu; Xueju Zhang; Xue Li; Zhen Guo; Haiyan Li; Peter York; Shuangying Gui; Jiwen Zhang
Journal:  Acta Pharm Sin B       Date:  2014-01-23       Impact factor: 11.413

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.